Ascletis Pharma CEO on IPO Performance, New Drugs, Revenue Targets

The transcript discusses the challenges and opportunities in the biotech industry, focusing on a company's innovative drug development and market strategies. It highlights the unpredictability of the market, the importance of regulatory approvals, and the competition between domestic and international firms. The company aims to expand its revenue beyond China while navigating regulatory frameworks and pricing pressures. Future prospects include new drug launches and potential profitability, emphasizing the role of R&D in driving innovation.

What are the expected timelines for the approval of new drugs?

How does the company view competition from international pharma companies?

What is the company's strategy for pricing its innovative drugs in the market?